Biodesy

Biodesy, Inc., now operating as BlueLight Therapeutics, is a venture-funded company established in 2013 that specializes in the development and manufacturing of cutting-edge bioanalytical instruments and reagents. These tools are designed to measure protein structural changes, which are critical in the drug discovery process. The company primarily serves pharmaceutical and biotechnology firms engaged in small molecule hit discovery. Biodesy's proprietary technology enables precise measurement of protein structural changes, facilitating the identification of potential drug candidates. The business operates in the bioanalytical research market and generates revenue through the sale of its instruments and reagents, as well as through collaborative research agreements. The company is based in South San Francisco, CA, and is known for its innovative approach and high-growth potential. Key clients include research institutions and pharmaceutical companies focused on drug development.

Keywords: bioanalytical instruments, protein structural changes, drug discovery, small molecule screening, biotechnology, pharmaceutical, reagents, proprietary technology, high-growth, venture-funded.